FDA Approved: LUMAKRAS — Original Application (Amgen Inc)

View source ↗

Summary

FDA approves Lumakras (sotorasib) from Amgen in an original application for the treatment of adults with KRAS G12C-mutant non-small cell lung cancer that has pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• LUMAKRAS (sotorasib)

Snippet

ORIG AP for LUMAKRAS (SOTORASIB)